Transcutaneous Levator Recession for Non-thyroid Lid Retraction

Eye Diseases Clinical Trial

Official title:

Transcutaneous Levator Recession for Non-thyroid Lid Retraction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05671120
• Other study ID #: levator recession
• Status: Completed
• Phase: N/A
• Start date: January 1, 2019
• Est. completion date: August 2, 2021

Study information

• Verified date: January 2023
• Source: Al-Azhar University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This work aims to describe and assess the efficacy of transcutaneous levator palpebrea superioris muscle recession as a surgical procedure for treatment of upper lid retraction of various causes other than thyroid eye disease

Recruitment information / eligibility

• Status: Completed
• Enrollment: 19
• Est. completion date: August 2, 2021
• Est. primary completion date: June 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 55 Years

Eligibility

Inclusion Criteria:

• Patients suffering from upper eyelid retraction of various causes other than thyroid eye disease

Exclusion Criteria:

• Patients refused to participate in the study, patients with systemic diseases causing lid retraction (such as Guillain-Barré syndrome), pseudo retractions, contralateral ptosis, local skin condition (as scar adherence), medication (such as sympathomimetic drugs, lithium, and steroid), neurological conditions (such as dorsal midbrain syndrome and hydrocephalus) and thyroid related lid retraction

Related Conditions & MeSH terms

• Eye Diseases

Intervention

Procedure:
• Transcutaneous levator recession
recession of the upper and lower eyelid retractors can improve the upper eyelid contour if the patient has lateral flare (common in TED). The choice of procedure depends on severity of lid retraction and associated features like proptosis, status of extraocular muscles, and corneal condition

Locations

Country	Name	City	State
Egypt	Ehab tharwat	Damieta	New Damietta

Sponsors (1)

Lead Sponsor	Collaborator
Al-Azhar University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Margin reflex distance (MRD1)	MRD1 is a commonly used parameter in the assessment of patients with blepharoptosis and is defined as the distance between the upper lid margin and the corneal reflex when the eye is in the primary position	Baseline
Primary	Margin reflex distance (MRD1)	MRD1 is a commonly used parameter in the assessment of patients with blepharoptosis and is defined as the distance between the upper lid margin and the corneal reflex when the eye is in the primary position	at one month post operative